SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is actively trending amidst intensifying discussions around its evolving utility, particularly concerning the forthcoming LITVM upgrade which could significantly expand its capabilities beyond a traditional payment coin. Community sentiment remains divided, with many anticipating a major upward movement while others voice skepticism and caution regarding ongoing market volatility and liquidity dynamics. Despite mixed views on immediate price action, long-term holders emphasize its perceived undervaluation and potential for broader adoption, fueled by recent positive external recognition.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is experiencing intense bearish sentiment following Amazon Pharmacy's aggressive entry into the GLP-1 weight loss market with branded Wegovy pills, directly challenging Hims' compounded offerings. This heightened competition, alongside a recent analyst downgrade citing overly optimistic 2026 estimates, is fueling widespread community discussion about the company's declining valuation and perceived lack of a sustainable competitive moat. While many investors are questioning management's strategy and anticipating further downside, a smaller contingent views the steep drop as a potential buying opportunity based on long-term growth in other healthcare verticals.

The Cosmos network consists of many independent, parallel blockchains, called zones, each powered by classical Byzantine fault-tolerant (BFT) consensus protocols like Tendermint. Some zones act as hubs with respect to other zones, allowing many zones to interoperate through a shared hub. The architecture uses classic BFT and Proof-of-Stake algorithms, instead of Proof-of-Work. Cosmos can interoperate with multiple other applications and cryptocurrencies, something other blockchains can’t do well. By creating a new zone, you can plug any blockchain system into the Cosmos hub and pass tokens back and forth between those zones, without the need for an intermediary.  While the Cosmos Hub is a multi-asset distributed ledger, there is a special native token called the atom. ATOM have three use cases: as a spam-prevention mechanism, as staking tokens, and as a voting mechanism in governance.  As a spam prevention mechanism, ATOM are used to pay fees. The fee may be proportional to the amount of computation required by the transaction, similar to Ethereum’s concept of “gas”. Fee distribution is done in-protocol and a protocol specification is described here.  As staking tokens, ATOM can be “bonded” in order to earn block rewards. The economic security of the Cosmos Hub is a function of the amount of ATOM staked. The more ATOM that are collateralized, the more “skin” there is at stake and the higher the cost of attacking the network. Thus, the more ATOM there are bonded, the greater the economic security of the network.  Atom holders may govern the Cosmos Hub by voting on proposals with their staked ATOM.

Cosmos

Cosmos (ATOM) is trending as its community actively discusses a significant tokenomics redesign, transitioning to a revenue-based economic model aimed at enhancing value and reducing sell pressure. Many investors are accumulating and staking ATOM, drawn by its high annual percentage yield and a strong belief in its 'Internet of Blockchains' vision for future interoperability, positioning it for long-term growth despite past volatility.

Mastercard, Inc. is a technology company, which engages in the provision of payment solutions for the development and implementation of credit, debit, prepaid, commercial, and payment programs through its brands including Mastercard, Maestro, and Cirrus. It also offers cyber and intelligence solutions. The company was founded in November 1966 and is headquartered in Purchase, NY.

Mastercard Incorporated - Ordinary Shares - Class A

Mastercard Inc

Mastercard is trending amid community discussion around a proposed credit card interest rate cap, with many clarifying its revenue primarily stems from transaction fees, not interest. This comes as the payment giant demonstrates robust performance, announcing significant shareholder returns and receiving favorable analyst upgrades. Mastercard is further solidifying its position through strategic expansion into AI-powered commerce and stablecoin partnerships, signaling continued growth and diversification in the evolving digital payment landscape.

Capital One Financial Corp. is a financial holding company, which engages in the provision of financial products and services. It operates through the following segments: Credit Card, Consumer Banking, and Commercial Banking. The Credit Card segment includes domestic consumer and small business card lending, and international card lending businesses. The Consumer Banking segment consists of branch-based lending and deposit gathering activities for consumers and small businesses. The Commercial Banking segment includes lending, deposit gathering and treasury management services to commercial real estate and commercial and industrial customers. The company was founded by Richard D. Fairbank on July 21, 1994 and is headquartered in McLean, VA.

Capital One Financial Corp.

Capital One is trending following a robust earnings beat that surpassed expectations, fueling optimism about its core domestic card and auto businesses. The financial community is actively discussing recent regulatory approvals for its acquisition of Discover Financial Services, a strategic move poised to significantly expand its market share and payment network capabilities. This development, alongside numerous analyst upgrades, positions Capital One for potential long-term growth within the credit card sector.

Visa, Inc. engages in the provision of digital payment services. It also facilitates global commerce through the transfer of value and information among a global network of consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It offers debit cards, credit cards, prepaid products, commercial payment solutions, and global automated teller machines. The company was founded by Dee Hock in 1958 and is headquartered in San Francisco, CA.

Visa Inc - Ordinary Shares - Class A

Visa Inc

Visa is trending due to a lively community debate surrounding a proposed credit card interest rate cap, as investors assess its true impact given Visa's revenue model relies on transaction volumes, not interest. Concurrently, the company's strategic expansion into stablecoin settlements and AI-driven commerce is a key talking point, offering a long-term growth narrative despite some recent frustration within the community regarding the stock's price action.

American Express Co. engages in the provision of card-issuing, merchant-acquiring, and card network businesses. Its products and services include credit cards, business credit cards, corporate programs, gift cards, savings accounts and CDs, and the American Express App. It operates through the following segments: the United States Consumer Services (USCS), Commercial Services (CS), International Card Services (ICS), Global Merchant and Network Services (GMNS), and Corporate and Other. The USCS segment includes proprietary consumer cards and provides services to United States consumers. The CS segment offers corporate and small business cards and provides services to United States businesses. The ICS segment provides consumers, small businesses, and corporate cards outside the United States. The GMNS segment is involved in operating a global payments network that processes and settles card transactions, acquires merchants, and provides multi-channel marketing programs and capabilities, services and data analytics. The Corporate and Other segment covers corporate functions and certain other businesses and operations. It also operates through the following geographical segments: United States, EMEA, APAC, LACC, and Other. The EMEA segment represents Europe, the Middle East, and Africa. The APAC segment refers to Asia Pacific, Australia, and New Zealand. The LACC segment focuses on Latin America, Canada, and the Caribbean. The Other segment includes net costs which are not directly allocated to specific geographic regions. The company was founded by Henry Wells, William G. Fargo, and John Warren Butterfield on March 28, 1850 and is headquartered in New York, NY.

American Express Co.

American Express is actively discussed amid political proposals to cap credit card interest rates, prompting community concerns about profitability across the financial sector. Despite this, conversation also highlights AXP's strategic focus on its premium customer base, exemplified by a refreshed Platinum card and a new crypto card partnership, appealing to affluent consumers and younger generations. This dual narrative positions AXP at the intersection of regulatory risk and a differentiated growth strategy in the evolving payments landscape.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is actively discussed as investors grapple with its stagnant stock performance despite Briumvi's robust sales and growing market share. Community sentiment is dominated by frustration over recent executive compensation, intense speculation about a potential buyout at the upcoming JPM Healthcare Conference, and optimism following significant setbacks for competing MS treatments.

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

JPMorgan Chase & Co.

JPMorgan Chase & Co

JPMorgan Chase is trending following a recent executive disclosure projecting higher-than-expected expenses for 2026, which has notably impacted its share price. This is generating community discussion around the bank's cost discipline and potential future profitability, alongside ongoing conversations about a proposed credit card interest rate cap and its strategic expansion into tokenized money-market funds on the Ethereum blockchain.

ETF Opportunities Trust - REX-Osprey XRP ETF

REX-Osprey XRP ETF

The REX-Osprey XRP ETF ($XRPR) is trending as the first U.S.-listed spot XRP ETF, attracting significant community attention since its launch. Investors are actively discussing its consistent net inflows and the potential for a "supply shock" from ETFs absorbing XRP supply, highlighting its role in making digital assets accessible in traditional portfolios.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>The deal broadens Cemtrex’s capabilities in high-reliability electronics, flight instrumentation, and advanced system design.</li><li>Cemtrex acquired 100% of Invocon’s outstanding shares for $7.06 million, according to an earlier press release.</li><li>Invocon’s technologies have been used for 17 space shuttle systems and 10 international space station systems, among others.</li></ul>Shares of Cemtrex Inc. (CETX) jumped nearly 30% in premarket trading on Friday after the company formally launched its Aerospace &amp; Defense segment following the acquisition of Invocon, a Texas-based aerospace and defense engineering firm.According to a press release in November last year, Cemtrex acquired 100% of Invocon’s outstanding shares for $7.06 million.Cemtrex said near-term priorities include maintaining customer continuity, expanding proposal activity across missile defense and aerospace programs, and evaluating additional strategic opportunities.<h2 class="st-heading-2">Acquisition Rationale</h2>The acquisition expands Cemtrex’s capabilities in high-reliability electronics, flight instrumentation, wireless data acquisition, and complex system design.Invocon brings nearly four decades of experience developing advanced instrumentation, wireless sensing, and telemetry systems for satellites, launch vehicles, missiles, and space-based platforms. Its technologies have supported major government programs, including 17 space shuttle systems and 10 international space station systems, and have flown on more than 40 shuttle missions and over 30 target missile flights.The company also maintains long-standing relationships with the Missile Defense Agency and has a strong intellectual property portfolio covering hypervelocity impact detection, advanced sensing, and flight-system telemetry.Last month, Invocon secured awards under the Missile Defense Agency’s SHIELD IDIQ contract, a multi-award program with a total ceiling of up to $151 billion.“With the acquisition closed, we are focused on expanding Invocon’s participation across missile defense modernization, prime contractor programs, and space systems where reliability and execution determine outcomes. SHIELD strengthens our access to programs designed specifically to move faster, deploy new capabilities more rapidly, and deliver layered defense solutions at scale,” said Saagar Govil, Cemtrex Chairman and CEO.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment for <a href="https://stocktwits.com/symbol/CETX">CETX</a> on Stocktwits flipped to ‘bullish’ from ‘bearish’ over the past 24 hours, amid ‘high’ message volumes.<figure class="image"><img src="https://news.stocktwits-cdn.com/CETX_png_28e815281c.webp" alt="CETX.png" width="922" height="97"><figcaption>CETX Sentiment Meter and Message Volumes at Premarket on Jan. 9, 2026 | Source: Stocktwits</figcaption></figure>One bullish user expects the stock price to climb up to $8-10 following the acquisition. It is currently trading at $3.7.<stembedurl>https://stocktwits.com/SouthMadeMack/message/641308617</stembedurl>Another user highlighted a potential technical indicator.<stembedurl>https://stocktwits.com/Crazzywt/message/641308447</stembedurl>Read also: <a href="https://stocktwits.com/news-articles/markets/cryptocurrency/balaji-srinivasan-backs-zcash-developers-after-team-exits-launches-new-wallet/cmU2aRwR4dE">Balaji Srinivasan Backs Zcash Developers After Team Exits And Launches New Wallet - ZEC Price Gains</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

Why Did CETX Stock Surge 30% In Pre-market Today?

Cemtrex has completed its acquisition of Texas-based engineering firm Invocon, establishing a new Aerospace & Defense segment.

Equity

5 ETFs to Buy for January 

5 ETFs to buy in January: momentum, small caps, chips, defense and healthcare shine as markets rally early in 2026 -- IWM, MTUM, SMH, XAR and IHE.

<ul class="summary-bullets"><li>The outlook includes $150 million to $170 million from DefenCath, with results weighted toward the first half of the year.</li><li>The company expects adjusted EBITDA for 2026 to be between $100 million and $125 million.</li><li>CorMedix is commercializing a portfolio of anti-infective products.</li></ul>Shares of CorMedix Therapeutics (CRMD) plunged 28% on Thursday after the company issued a cautious full-year 2026 outlook, signalling revenue could come in below 2025 levels.<a href="https://stocktwits.com/symbol/CRMD">CRMD</a> was among the top trending stocks at the time of writing.CorMedix posted net revenue of around $127 million in the fourth quarter (Q4) of 2025 and $310 million for the full year, with pro forma full-year revenue of about $400 million. Adjusted earnings before interest, tax, depreciation and amortization (EBITDA) for Q4 is expected to range between $77 million and $81 million.<h2 class="st-heading-2">Full-Year Expectations</h2>For 2026, CorMedix expects revenue between $300 million and $320 million, including $150 million to $170 million from DefenCath, with performance weighted toward the first half of the year. DefenCath is an FDA-approved catheter lock solution used to reduce bloodstream infections in certain adult dialysis patients with central venous catheters.Adjusted EBITDA for 2026 is projected at $100 million to $125 million, supported by $35 million in annualized cost synergies from the Melinta acquisition. Last August, CorMedix acquired Melinta Therapeutics in a $300 million deal, which also includes up to $25 million in regulatory milestone payments and royalties.<h2 class="st-heading-2">Key Updates</h2>Commercial momentum continues to be driven by DefenCath, which is seeing strong utilization and patient growth among outpatient dialysis customers. CorMedix noted that reimbursement for DefenCath will decline in the second half of 2026 as the Transitional Drug Add-on Payment Adjustment&nbsp;(TDAPA) transitions to a post-TDAPA add-on adjustment, pressuring pricing later in the year.However, the company expects reimbursement to improve in 2027, potentially supporting higher pricing compared to late 2026.On the clinical front, Phase 3 data from the ReSPECT study of REZZAYO antifungal medication is expected in Q2 2026, while enrollment continues in a Phase 3 study of DefenCath in total parenteral nutrition (TPN) patients. CorMedix is also commercializing a portfolio of anti-infective products.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Despite the sharp intraday decline, retail sentiment on Stocktwits flipped to ‘bullish’ from ‘bearish’ a day earlier, amid ‘high’ message volumes. CRMD was among the top trending tickers on the platform.<img src="https://news.stocktwits-cdn.com/CRMD_jpg_84acb69cec.webp" alt="CRMD.jpg">One user questioned the company’s financial outlook.<stembedurl>https://stocktwits.com/Spoonorama/message/641198820</stembedurl>Another user sounded skeptical about the company’s second-half performance.<stembedurl>https://stocktwits.com/Brunoez/message/641203929</stembedurl>Over the past year, the stock has declined about 20%.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/why-did-mltx-stock-jump-45-in-pre-market-today/cmUbJFWR4Pt">Why Did MLTX Stock Jump 45% In Pre-Market Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the CorMedix logo is seen displayed on the screen of a tablet. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

Why Did CRMD Stock Crash 28% Today?

CorMedix announced that for 2026, it expects revenue between $300 million and $320 million, compared to $310 million it reported in the full year 2025, according to preliminary data.

<ul class="summary-bullets"><li>Daniel Jester of BMO Capital downgraded the stock to ‘Market Perform’ from ‘Outperform’, citing the low likelihood of a competing offer emerging.</li><li>Wolfe Research said the shares now offer little remaining upside.</li><li>Morgan Stanley also downgraded the stock to ‘Equal Weight’ and described Hg Capital’s proposal as reasonable.</li></ul>OneStream Inc. (OS) drew a wave of analyst downgrades following its agreement to be taken private by Hg Capital in an all-cash deal that values the financial software company at about $6.4 billion.&nbsp;Several Wall Street firms moved quickly to reset expectations, citing limited upside now that the stock trades close to the proposed buyout price.<h2 class="st-heading-2">Multiple Firms Reassess Valuation</h2>Daniel Jester of BMO Capital downgraded the stock to ‘Market Perform’ from ‘Outperform’ and trimmed his price target to $24 per share from $25, according to TheFly. The analyst said the downgrade reflects the agreed acquisition price and the low likelihood of a competing offer emerging.&nbsp;Wolfe Research echoed that view, cutting OneStream to ‘Peer Perform’ from ‘Outperform.’ The firm said the shares now offer little remaining upside since they trade near the deal price.Morgan Stanley also downgraded the stock to ‘Equal Weight’ from ‘Overweight’ while cutting its price target to $24 from $27. The firm described Hg Capital’s proposal as reasonable and said it expects the transaction to clear regulatory hurdles.&nbsp;The firm highlighted BlackLine Inc. (BL) as a potential beneficiary of the transaction, suggesting the buyout may be positive for comparable software assets.&nbsp;<a href="https://stocktwits.com/symbol/OS">OneStream stock</a> inched 0.1% lower in Wednesday’s premarket.&nbsp;On Stocktwits, retail sentiment around the stock jumped to ‘extremely bullish’ from ‘neutral’ territory the previous day. Message volume shifted to ‘extremely high’ from ‘high’ levels in 24 hour.&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_01_07_052407_png_a622e2f9c9.webp" alt="OS’s Sentiment Meter and Message Volume as of 05:20 a.m. ET on Jan. 7, 2026 | Source: Stocktwits" width="931" height="109"><figcaption>OS’s Sentiment Meter and Message Volume as of 05:20 a.m. ET on Jan. 7, 2026 | Source: Stocktwits</figcaption></figure><h2 class="st-heading-2">Mizuho Questions Chances Of A Bidding War</h2>Mizuho analyst Siti Panigrahi downgraded OneStream to ‘Neutral’ from ‘Outperform’ and trimmed the firm’s price target to $24. The firm said it does not expect a higher bid, noting that the agreed valuation aligns with recent software take-private transactions.&nbsp;OneStream’s acquisition agreement will take the company off public markets, reshaping its ownership structure. Under the terms of the deal, holders of OneStream stock will receive $24.00 per share in cash for their positions, a 31% premium to the stock’s closing price on January 5.&nbsp;Hg will become the majority voting stakeholder, and OneStream is expected to benefit from expanded resources to accelerate its artificial intelligence-driven offerings for corporate finance teams.&nbsp;OS stock has declined by over 13% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/bmnr-tom-lee-bitcoin-never-topped-during-manufacturing-contraction/cmxyHoIR4cn">BMNR’s Tom Lee Agrees Bitcoin Has Never Topped During Manufacturing Contraction</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Traders work on the floor of the New York Stock Exchange.

OneStream Stock Faces Wave Of Analyst Downgrades As Hg Capital Deal Caps Upside

Several Wall Street firms moved quickly to reset expectations, citing limited upside now that the stock trades close to the proposed buyout price.

<ul class="summary-bullets"><li>Critical Metals is also in the spotlight after President Donald Trump renewed his calls for the U.S. to take control of Greenland.</li><li>Critical Metals’ recent joint venture with a Romanian state-owned company gives it long-term rights to 50% of Tanbreez output and raises the company’s total Tanbreez offtake to 75%.</li><li>An earlier Reuters report said that Trump administration officials were considering a stake in Critical Metals.</li></ul>Shares of Critical Metals Corp. (CRML) rallied over 23% on Tuesday after jumping over 251% in the past six months as speculations rose around the company’s strategic Greenland Tanbreez rare earth asset.Despite the stock’s steep rally in the last half a year, retail investors are still firmly bullish on the stock.The stock is also in the spotlight after President Donald Trump renewed his calls for the U.S. to take control of Greenland, shortly after the arrest of Venezuelan President Nicolas Maduro.<h2 class="st-heading-2">Rare Earths Interest</h2>Tanbreez in Greenland is among the largest known rare-earth deposits in the world, with some estimates suggesting that it contains over 27% of heavy rare-earth elements. The site also provides an important supply chain advantage because of its direct shipping access to the North Atlantic Ocean.Critical Metals acquired Greenland’s Tanbreez rare earth in mid 2024 for $5 million in cash and $211 million in stock.Recently, a Reuters report alleged that Critical Metals is expected to finalize its rare earths project in Greenland by the first quarter of 2026 wherein the remaining 25% of off-take agreements for its rare earths Tanbreez project in south Greenland will be completed. The company has already completed the sale of 75% of the planned output to the U.S. and Europe, as per the report.An earlier Reuters <a href="https://stocktwits.com/news-articles/markets/equity/critical-metals-anticipates-closing-rare-earths-supply-deal-in-greenland-by-2026-report/cL7BQ0iRECJ">report</a> also said that the Trump administration officials were considering a stake in Critical Metals.Critical Metals’ recent joint venture with a Romanian state-owned company gives it long-term rights to 50% of Tanbreez output and raises the company’s total Tanbreez offtake to 75%.Last month, Trump said that Greenland was an important part of U.S. national security. The country has a rich rare earths deposit. The U.S. is seeking to reduce its reliance on China for critical minerals as the Trump administration steps up efforts to strengthen domestic supply chains.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around CRML stock jumped to ‘extremely bullish’ from ‘bullish’ territory over the past 24 hours amid ‘high’ message volume.One bullish user said that the Greenland situation was far bigger than Trump and the recent deals with Romania and the U.S. are positive.<stembedurl>https://stocktwits.com/Crypto_Jim/message/640990291</stembedurl>&nbsp;Another user highlighted the China risk and said rare earth stocks like CRML could surge to 100%.<stembedurl>https://stocktwits.com/fitoto/message/640990773</stembedurl>&nbsp;<a href="https://stocktwits.com/symbol/CRML">Shares of CRML </a>were among the top trending tickers on Stocktwits. The stock is up over 78% in the past year.For updates and corrections, email newsroom[at]stocktwits[dot]com.&nbsp;

 Rare-earth mine in Baiyun'ebo or Bayan Obo. Baiyun'ebo or Bayan Obo is a mining town in Inner Mongolia in China.

CRML Shares In Spotlight After Surging Over 251% In Six Months — Why Is Retail Still Bullish?

Retail investors are optimistic around the company’s strategic Greenland Tanbreez rare earth asset. 

Bet on These 3 Small-Cap ETFs to Ride the January Effect

Small caps jump early in 2026, reviving the January Effect. ETFs like VTWO offer diversified exposure to potential seasonal and macro-driven gains.  

<ul class="summary-bullets"><li>The rare earths company has already completed the sale of 75% of the planned output to the U.S. and Europe, CEO Tony Sage said.&nbsp;</li><li>Critical Metals would also be open to investments from Washington, CEO Sage told Reuters.&nbsp;</li><li>The company is seeking a diversified supply to limit geopolitical risk.</li></ul>Critical Metals Corp. (CRML) is reportedly expected to finalize its rare earths project in Greenland by the first quarter of 2026.The company’s chief executive officer, Tony Sage, told Reuters that the remaining 25% of off-take agreements for its rare earths Tanbreez project in south Greenland is likely to be completed early next year, and the company would be open to an investment from Washington. As per an earlier Reuters report, Trump administration officials were <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/business/trump-administration-eyes-stake-company-developing-greenland-rare-earths-mine-2025-10-03/">considering</a> a stake in Critical Metals.Critical Metals has already completed the sale of 75% of the planned output to the U.S. and Europe, according to the report. The company is looking to keep its supply diversified to limit geopolitical risk, Sage said.<a href="https://stocktwits.com/symbol/CRML">Shares of CRML</a> climbed 0.14% on Wednesday morning at the time of writing.<h2 class="st-heading-2">Rare Earths Interest</h2>Growing interest from the Middle East indicates that energy-rich states are making efforts to build rare-earth processing capacity, Sage told Reuters. This includes potential processing partners in Saudi Arabia, Qatar, Bahrain, Oman, and the U.A.E., as well as the lower power costs and faster permitting than in the U.S. and Europe.The U.S. is aiming to reduce its reliance on China for critical minerals, which is currently the leader in the space. The Trump administration is stepping up efforts to strengthen domestic supply chains for critical minerals amid escalating trade tensions with the Asian country.Earlier this month, President Donald Trump touted Greenland as an important part of U.S. national security, adding that he had appointed a special envoy to the island to lead the charge.<h2 class="st-heading-2">Tanbreez Deposit</h2>Tanbreez in Greenland is among the largest known rare-earth deposits in the world, with some estimates suggesting that it contains over 27% of heavy rare-earth elements. The site also provides an important supply chain advantage because of its direct shipping access to the North Atlantic Ocean.Critical Metals’ recent joint venture with a Romanian state-owned company gives it long-term rights to 50% of Tanbreez output and raises the company’s total Tanbreez offtake to 75%.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around CRML shares trended in the ‘bearish’ territory over the past day amid ‘low’ message levels.<figure class="image"><img style="aspect-ratio:1281/160;" src="https://news.stocktwits-cdn.com/Screenshot_2025_12_31_at_9_59_25_PM_png_773cd7a9c7.webp" alt="On Stocktwits, retail sentiment around CRML shares trended in the ‘bearish’ territory over the past day amid ‘low’ message levels." width="1281" height="160"></figure>Shares of CRML have gained over 5% in the past year.For updates and corrections, email newsroom[at]stocktwits[dot]com. &nbsp;

Drag-line excavator mines rare earth materials. (Photo by Kostiantyn Liberov/Libkos/Getty Images)

Critical Metals Anticipates Closing Rare Earths Supply Deal In Greenland By Q1 2026: Report 

Critical Metals expects the remaining 25% of offtake agreements for its rare earths project in south Greenland to be completed early next year, as per the company’s CEO. 

Critical Metals Anticipates Closing Rare Earths Supply Deal In Greenland By Q1 2026: Report

<ul class="summary-bullets"><li>Innodata&nbsp;stock has mainly traded sideways in 2025 and remains well supported technically.</li><li>It is still up about 32% year to date despite missing the broader AI rally.</li><li>Retail engagement has surged on Stocktwits, while all analysts covering the stock have bullish recommendations.</li></ul>Small-cap Innodata Inc. (INOD) has come onto the radar of retail traders as the stock slowly recovers from the steep pullback following its early-October peak. Notwithstanding the volatility seen in the second half of the year,&nbsp;<a href="https://stocktwits.com/symbol/INOD">Innodata’s stock</a> is still up about 32%. The gains, however, are underwhelming relative to some artificial intelligence (AI) plays.Innodata has an AI connection, though in a more peripheral sense. The company functions as an AI enabler, providing data engineering services to a range of technology clients, including hyperscalers, financial services firms, and government agencies, and can rightly be called a "picks-and-shovels" play, a term used to refer to supplying essential tools and infrastructure to a booming industry.Based in New Jersey, Innodata offers a broad suite of capabilities, including data collection and annotation, data curation and enrichment, generative AI and large language model (LLM) support, AI model testing and validation, and content engineering and transformation.<h2 class="st-heading-2">Retail Interest Builds</h2>Innodata has drawn the attention of retail traders due to its credentials as an AI play. The one-year change in the follower count for the stock on Stocktwits is 141%. The message volume change on the stream over 30 days increased by about 550%.Retail sentiment toward the stock was ‘bullish’ as of early Tuesday, although the mood has seen volatility throughout the year.<figure class="image"><img style="aspect-ratio:719/439;" src="https://news.stocktwits-cdn.com/Screenshot_2025_12_30_at_7_08_33_AM_png_2f22f8b2a0.webp" alt="Screenshot 2025-12-30 at 7.08.33 AM.png" width="719" height="439"></figure>&nbsp;Retail chatter <a href="https://stocktwits.com/AI_Bull_/message/640382964">surrounded</a> a strategically significant “new relationship” that the company flagged on the third-quarter earnings call. Since the company stated that the unnamed partner is a leader in the military and government sectors, retail watchers played a guessing game, throwing up names such as Lockheed Martin and Palantir.Another watcher <a href="https://stocktwits.com/Stocks1234567891011/message/640369151">said</a> the Innodata story is only beginning.&nbsp;According to Koyfin, the average analyst price target for Innodata is $93.75, implying roughly 80% upside from current levels. All four analysts covering the stock have either a ‘Buy’ or ‘Strong Buy’ rating.In an October note, Wedbush analyst Daniel Ives named Innodata as among the top candidates that are likely to be acquired this year.&nbsp;<h2 class="st-heading-2">How INOD Stock Performed This Year</h2>Innodata did not partake substantially in the strong AI rally seen on either side of the across-the-board April tariff sell-off. The year’s move can be characterized as broadly sideways, interspersed with small rallies and pullbacks. Following the release of Innodata’s second-quarter results in late July, the stock picked up some upward momentum. The uptrend lasted for a month, until early October, when the stock began to retrace the move.&nbsp;&nbsp;The stock is currently well-supported by its 200-day simple moving average (SMA) ($51.30) on a one-year chart. The 14-day relative strength index (RSI) is currently at 42, suggesting the stock is approaching the neutral zone.<img src="https://news.stocktwits-cdn.com/INOD_YTD_Stock_Trajectory_png_01a69319c8.webp" alt="INOD YTD Stock Trajectory.png">Source: Koyfin<h2 class="st-heading-2">How Innodata’s Fundamentals Stack Up</h2>Innodata’s third-quarter results, released in early November, showed 20% year-over-year (YoY) growth in revenue to $62.6 million, and adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) more than doubled to $42.2 million. The net income was at $8.3 million.&nbsp;Looking ahead, the company reiterated its guidance for 45% or more YoY organic growth for 2025, and hinted at “continued transformative growth in 2026 based on new wins and strong momentum."Last month, the company launched Innodata Federal, a dedicated government-focused business unit designed to deliver mission-critical AI solutions to U.S. defense, intelligence, and civilian agencies.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/tesla-ev-business-feels-heat-what-automotive-delivered-in-2025/cL74yLcREUi">Tesla’s Core EV Business Is Feeling The Heat — What Its Automotive Segment Really Delivered In 2025</a>

In this photo illustration, the Innodata logo is seen displayed on a smartphone and in the background. 

Innodata Emerges As Picks-And-Shovels AI Play Poised For 80% Upside Ahead – And It Is Back On Retail's Radar

Innodata operates as an AI enabler rather than a core AI platform, but is delivering strong revenue and EBITDA growth and guiding for 45%+ organic growth in 2025.

Innodata Emerges As Picks-And-Shovels AI Play Poised For 80% Upside Ahead – And It Is Back On Retail’s Radar

Innodata operates as an AI enabler rather than a core AI platform, but is delivering strong revenue and EBITDA growth and guiding for 45%+ organic growth in 2025.


<ul class="summary-bullets"><li>Nutriband’s shareholders will retain a 10% shareholding in Earth Vision Bio.</li><li>The firm will use the proceeds from the sale of Pocono Pharma to continue developing AVERSA Fentanyl.</li><li>It expects annual U.S. sales from AVERSA Fentanyl to reach $80 million to $200 million.</li></ul>Shares of Nutriband Inc. (<a href="https://stocktwits.com/symbol/NTRB">NTRB</a>) surged more than 18% on Monday after the company announced an agreement to sell 90% stake in its subsidiary, Pocono Pharmaceutical, to EarthVision Bio for $5 million.Nutriband’s shareholders will retain a 10% shareholding in Earth Vision Bio following the acquisition, it stated.Nutriband will use the proceeds from the sale of Pocono Pharma towards its continued development of AVERSA Fentanyl. The company develops transdermal drug delivery systems that are focused on preventing abuse and misuse of medications like opioids using its proprietary AVERSA Technology.<h2 class="st-heading-2">Bet On Abuse-Deterrent Aversa Fentanyl</h2>The U.S. government has been cracking down on illicit fentanyl. U.S. President Donald Trump earlier this month signed an executive order designating it as a weapon of mass destruction and recognizing the substance as a direct threat to U.S. national security.Nutriband’s AVERSA Fentanyl uses its abuse-deterrent technology, which is designed to improve the safety profile of transdermal drugs that are susceptible to abuse, such as fentanyl, while making sure these drugs remain accessible to patients who need them.Nutriband has been partnering with Kindeva Drug Delivery to develop AVERSA Fentanyl, which combines Nutriband’s abuse-deterrent technology with Kindeva’s FDA-approved fentanyl patch. It expects annual U.S. sales from AVERSA Fentanyl to reach $80 million to $200 million.Nutriband had signed a non-binding Letter of Intent (LOI) with Qvanta Group of Companies to explore potential collaboration areas, including secure AI and analytics platforms for regulated pharmaceutical data, and cybersecurity that support abuse-deterrent technologies.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment around NTRB trended in “extremely bullish” territory amid “high” message volumes.&nbsp;<figure class="image"><img style="aspect-ratio:639/68;" src="https://news.stocktwits-cdn.com/ntrb_PNG_d487765902.webp" alt="Retail sentiment around NTRB trended in “extremely bullish” territory amid “high” message volumes. " width="639" height="68"></figure>For updates and corrections, email newsroom[at]stocktwits[dot]com. &nbsp;

A researcher works in the clinical-stage biopharmaceutical company Xencors new laboratory in Pasadena. (Photo by Sarah Reingewirtz/MediaNews Group/Los Angeles Daily News via Getty Images)

What’s Driving Nutriband Shares Higher Today?

Nutriband has agreed to sell 90% of its stake in its subsidiary Pocono Pharmaceuticals for $5 million. 

Will the Ongoing Market Rally Continue in 2026? ETFs in Focus

S&P 500 momentum and retail inflows set the stage for a potential 2026 rally, with ETFs offering ways to ride the bullish trend.

BlackRock Institutional Trust Company N.A. - iShares Russell 2000 ETF

Yes — Rates Move Meaningfully Lower

Short-Term Dip, No Lasting Impact

No — Mostly Political Noise

Other – Comment Below

President Trump says he’s directing $200 billion into mortgage bond purchases to bring down rates and improve housing affordability. With questions around execution, authority, and real market impact, do you think this move will actually lower mortgage rates in 2026?

Will Trump’s Mortgage Bond Plan Actually Lower Rates in 2026?

Current Price	$260.23
Prev Close	$258.27
Open	$259.58
Dividend Yield	N/A
50-Day Moving Average	$246.97
Beta	N/A
Avg. Volume	35.14M
PE Ratio	N/A

52-Week High	$261.56
52-Week Low	$171.73
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

IWM
iShares Russell 2000 ETF

Feed

News

Sentiment

Fundamentals

Info

Latest IWM News

IWMiShares Russell 2000 ETF